Strata Skin Sciences Current Ratio 2010-2024 | SSKN
Strata Skin Sciences current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Strata Skin Sciences Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2024-09-30 |
$0.02B |
$0.01B |
1.13 |
2024-06-30 |
$0.01B |
$0.01B |
1.14 |
2024-03-31 |
$0.01B |
$0.01B |
1.05 |
2023-12-31 |
$0.02B |
$0.01B |
1.28 |
2023-09-30 |
$0.02B |
$0.01B |
1.64 |
2023-06-30 |
$0.02B |
$0.01B |
1.51 |
2023-03-31 |
$0.02B |
$0.01B |
1.11 |
2022-12-31 |
$0.02B |
$0.01B |
1.12 |
2022-09-30 |
$0.02B |
$0.01B |
1.33 |
2022-06-30 |
$0.02B |
$0.01B |
1.30 |
2022-03-31 |
$0.02B |
$0.01B |
1.32 |
2021-12-31 |
$0.02B |
$0.01B |
1.56 |
2021-09-30 |
$0.02B |
$0.01B |
1.65 |
2021-06-30 |
$0.02B |
$0.02B |
1.32 |
2021-03-31 |
$0.02B |
$0.02B |
1.20 |
2020-12-31 |
$0.03B |
$0.02B |
1.32 |
2020-09-30 |
$0.03B |
$0.02B |
1.34 |
2020-06-30 |
$0.02B |
$0.02B |
1.44 |
2020-03-31 |
$0.02B |
$0.02B |
1.36 |
2019-12-31 |
$0.02B |
$0.02B |
1.35 |
2019-09-30 |
$0.02B |
$0.01B |
1.97 |
2019-06-30 |
$0.02B |
$0.01B |
2.12 |
2019-03-31 |
$0.02B |
$0.01B |
2.32 |
2018-12-31 |
$0.02B |
$0.01B |
2.69 |
2018-09-30 |
$0.02B |
$0.01B |
4.55 |
2018-06-30 |
$0.02B |
$0.00B |
4.77 |
2018-03-31 |
$0.01B |
$0.01B |
1.15 |
2017-12-31 |
$0.01B |
$0.01B |
1.03 |
2017-09-30 |
$0.01B |
$0.01B |
1.64 |
2017-06-30 |
$0.01B |
$0.01B |
1.35 |
2017-03-31 |
$0.01B |
$0.01B |
1.39 |
2016-12-31 |
$0.01B |
$0.01B |
1.75 |
2016-09-30 |
$0.01B |
$0.01B |
2.03 |
2016-06-30 |
$0.01B |
$0.00B |
2.18 |
2016-03-31 |
$0.01B |
$0.01B |
1.96 |
2015-12-31 |
$0.01B |
$0.01B |
1.69 |
2015-09-30 |
$0.01B |
$0.02B |
0.78 |
2015-06-30 |
$0.01B |
$0.02B |
0.81 |
2015-03-31 |
$0.01B |
$0.00B |
3.57 |
2014-12-31 |
$0.02B |
$0.00B |
7.87 |
2014-09-30 |
$0.02B |
$0.00B |
5.19 |
2014-06-30 |
$0.01B |
$0.01B |
1.63 |
2014-03-31 |
$0.01B |
$0.01B |
1.31 |
2013-12-31 |
$0.01B |
$0.01B |
1.83 |
2013-09-30 |
$0.00B |
$0.00B |
1.37 |
2013-06-30 |
$0.02B |
$0.00B |
4.39 |
2013-03-31 |
$0.02B |
$0.00B |
10.22 |
2012-12-31 |
$0.01B |
$0.00B |
3.21 |
2012-09-30 |
$0.02B |
$0.00B |
6.22 |
2012-06-30 |
$0.02B |
$0.00B |
7.69 |
2012-03-31 |
$0.02B |
$0.00B |
15.14 |
2011-12-31 |
$0.03B |
$0.00B |
20.07 |
2011-09-30 |
$0.02B |
$0.00B |
13.55 |
2011-06-30 |
$0.02B |
$0.00B |
17.28 |
2011-03-31 |
$0.03B |
$0.00B |
15.78 |
2010-12-31 |
$0.03B |
$0.00B |
18.41 |
2010-09-30 |
$0.04B |
$0.00B |
20.02 |
2010-06-30 |
$0.03B |
$0.00B |
15.29 |
2010-03-31 |
$0.03B |
$0.00B |
18.58 |
2009-12-31 |
$0.03B |
$0.00B |
16.75 |
2009-09-30 |
$0.03B |
$0.00B |
16.51 |
2009-06-30 |
$0.01B |
$0.00B |
6.03 |
2009-03-31 |
$0.01B |
$0.00B |
8.34 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Information Systems |
$0.013B |
$0.033B |
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.
|